documents: FDA-2007-D-0369-0376
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2007-D-0369-0376 | FDA | FDA-2007-D-0369 | Supplemental Comment from GlaxoSmithKline | Supporting & Related Material | Background Material | 2016-02-19T05:00:00Z | 2016 | 2 | 2016-02-19T19:50:20Z | 0 | 0 | 0900006481e7873d |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref